Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | quality defensive · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | ~$347 (≈ -18% vs spot) — precision reflects LOW valuation confidence |
| 12-mo scenario PWEV | ~$449 (≈ +6% vs spot) |
| Next catalyst | 2026-11-03 — Quarterly earnings |
| Primary thesis-break | Total revenue growth, YoY < 0.04 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · quality defensive · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $423 |
| Triangulated Fair Value | $347 (-18% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $449 (+6% vs spot · 12m PWEV) |
| Forward P/E | 55.1x |
| Market Cap | $34B |
| 52-Week Range | $339–$764 (intraday high and low over the trailing 52 weeks of the stock's own daily bars) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors are blended at fixed declared weights, each counted separately; the Monte Carlo, the scenario PWEV and the DCF's exit-multiple terminal all rest on the same base multiple, so where they agree it is partly by construction — not independent corroboration. Figures reconciled to Alpha Vantage 2026-10-09. Each chart below sits with the part of the thesis it evidences.
General research, published identically to every reader. Not personal financial advice. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Next catalyst |
|---|---|---|---|
| 59.8/100 (59th pct) | +10% 1yr expected | Hold | 24d — Quarterly earnings |
Full breakdown — conviction components, probability-return distribution, decision rules, factor & portfolio interaction and the catalyst timeline — in the Decision Support sections below. Model output for research; not personal financial advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $347 (-18% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $423 (10 October 2026) Axon trades on 55 times forward earnings and a high multiple of revenue, against peer medians a fraction of that. Spot therefore embeds sustained premium growth and margin durability well beyond the modelled base path. The engine's anchors disagree: probability-weighting the scenario tree gives $449, the twelve-month target is $430, and the triangulated fair value is $347, leaving the shares trading rich to that anchor set by -18%. The multiple drives most of the simulated dispersion, so the share price rests on the market's willingness to sustain a premium rating rather than on near-term earnings power; base-scenario earnings and the simulation's implied median earnings sit close to each other, which locates the disagreement squarely in the rating rather than in the forecast. An operating margin of 2.6% (reported GAAP, TTM to Jun 2026) is a genuine achievement for a business carrying a hardware component, but it does not support this multiple on its own. HOLD follows. The most damaging risk is simple multiple compression toward the peer median with earnings entirely intact — no operational disappointment required.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($423) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural bear carries the heaviest single bear weight and a credible mechanism. Axon sells almost entirely to government agencies; a sustained squeeze on federal, state and municipal budgets would hit new contract awards, slow cloud-seat expansion and defer hardware refresh cycles simultaneously, because all three are funded from the same appropriations rather than from independent budget lines. The path expresses this as revenue contracting, operating margin compressing as research spend and a rising capital line are carried on a shrinking top line, and the multiple falling toward the peer group. That produces a target below the 52-week low. At this forward multiple there is no valuation cushion: a budget-driven demand shock compresses earnings and the rating together rather than in sequence, and net debt of ~$1.1B leaves no balance-sheet capacity to defend the equity while it happens.
Key Debate
P/E Multiple explains 68% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 55.3× consensus forward EPS, vs the house DCF terminal 30.0×, and a peer median 38.3×. The house DCF sits 48% below spot, so the market is pricing in more than the house case — roughly 4.9pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 3.7 | 3.2 | High |
| EPS | 7.7 | 7.7 | Medium |
| Target price | 704.1 | 429.8 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Defense-Budget Cuts / Aero-Production Halt' downside ($202) to a 'Bull — Re-Rate' bull case ($829); the probability-weighted blend (PWEV $449) is +6% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Defense-Budget Cuts / Aero-Production Halt | 20% | $202 | -52% |
| Cyclical Downturn — Air-Traffic / Program Recession | 17% | $346 | -18% |
| Base — Backlog + Aftermarket | 35% | $483 | +14% |
| Growth — Rearmament / Air-Traffic Recovery | 20% | $649 | +54% |
| Bull — Re-Rate | 8% | $829 | +96% |
| Probability-Weighted (PWEV, after SBC dilution) | — | $449 | +6% |
SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (3.5% of shares, on SBC ≈ 23% of revenue), trimming the gross PWEV of $465 to $449 (-3.4%). SBC is charged once, as dilution — never also deducted from FCF.
Scenario rationale — the driver path behind every target:
- Structural — Defense-Budget Cuts / Aero-Production Halt (20%, $202). Structural impairment — defense-budget cuts / aero-production halt: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Cyclical Downturn — Air-Traffic / Program Recession (17%, $346). Cyclical downturn — defense budgets + commercial-aero OE/aftermarket cycle + program execution weakens for 1–2 years before normalising.
- Base — Backlog + Aftermarket (35%, $483). Mid-cycle — normalised defense budgets + commercial-aero OE/aftermarket cycle + program execution; disciplined capital allocation; steady returns.
- Growth — Rearmament / Air-Traffic Recovery (20%, $649). Upside — rearmament + air-traffic recovery lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Re-Rate (8%, $829). Upside tail — sustained tight conditions or a structural re-rate on rearmament + air-traffic recovery.
Valuation Triangulation
Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the scenario PWEV, any DCF's exit-multiple terminal and any peer re-rate key off a market multiple, so they are not independent; only a DCF's explicit-period cash flows are multiple-free, and its terminal usually carries most of its value. The discipline is to read the spread, not to treat four numbers as four independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $400 | -5% | 21% (declared 15%) |
| Peer P/E re-rate | multiple | $294 | -31% | 14% (declared 10%) |
| Peer EV/Revenue re-rate | multiple | $198 | -53% | 0% — cross-check only |
| Scenario PWEV | multiple | $449 | +6% | 34% (declared 25%) |
| DCF (5-year + exit-multiple terminal) | cash flow + terminal × | $221 | -48% | 31% (declared 35%) |
| Triangulated (weighted) | — | $347 | -18% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way. The company-lever row in the Sensitivity section is an illustrative EBIT × multiple value, not a sum-of-parts anchor.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $400 + scenario PWEV $449, ≈ spot); the weighted blend $347 (-18%) sits below it because the exit-multiple DCF ($221) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $400 and 45% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (68% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — explicit-period cash flows with an exit-multiple terminal
A 5-year cash-flow path discounted at a WACC of 8.5%, plus a terminal value of final-year FCF × 30.0x — a terminal multiple equal to 0.85 × the base multiple that the Monte Carlo and the scenario tree also use → $221. The terminal value is 85% of enterprise value, so this anchor moves with the multiple assumption. Weighted 31% in the blend; its exit-multiple terminal ties it to a market multiple, so it is not an independent vote.
Peer benchmarking — relative value
Against its 4 peers in the same GICS sub-industry, re-rating to their median forward multiple (P/E 38.3x) implies $294. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 14% so market sentiment does not set the fair value.
Across all anchors the spread is 85% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 21.0x | 25.5x | 30.0x | 34.5x | 39.0x |
|---|---|---|---|---|---|
| 6.5% | $177 | $210 | $243 | $276 | $309 |
| 7.5% | $169 | $200 | $232 | $263 | $295 |
| 8.5% | $161 | $191 | $221 | $251 | $281 |
| 9.5% | $154 | $183 | $211 | $240 | $269 |
| 10.5% | $147 | $175 | $202 | $229 | $257 |
DCF/share — revenue CAGR Δ × model op-margin Δ (Δ applied to the DCF's house margin path)
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $166 | $178 | $191 | $203 | $216 |
| -1.5pp | $179 | $192 | $206 | $219 | $232 |
| +0.0pp | $193 | $207 | $221 | $236 | $250 |
| +1.5pp | $207 | $223 | $238 | $253 | $269 |
| +3.0pp | $223 | $239 | $256 | $272 | $288 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $191 | $256 | $65.00 |
| Terminal × ±15% | $191 | $251 | $60.00 |
| Model op margin ±3pp | $193 | $250 | $57.00 |
| WACC ±1pp | $211 | $232 | $20.00 |
| Capex intensity ±15% | $213 | $230 | $17.00 |
Company lever — value at the base multiple vs Aerospace & Defense multiple (base 57.0x)
| Multiple | 39.9x | 48.4x | 57.0x | 65.5x | 74.1x |
|---|---|---|---|---|---|
| Value at the base multiple (EBIT × multiple; illustrative, not a blend anchor) | $354 | $433 | $512 | $590 | $670 |
Illustrative: segment EBIT × multiple, plus net cash, over basic shares — it does not enter the triangulated fair value.
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| GE | 50.0× | 7% | 20% | direct | 100% |
| RTX | 26.6× | 7% | 13% | segment | 50% |
| LMT | 16.3× | 7% | 11% | broad | 25% |
| HWM | 53.8× | 7% | 28% | direct | 100% |
Quality-weighted forward P/E: 44.1× (simple median 38.3×). Direct peers count 100%, segment 50%, broad 25%.
Valuation-anchor screen: DCF (Gordon) (low-confidence cross-check (>50% below median)). Anchor median 293.7. Extreme/excluded anchors carry no headline weight.
Historical-range cross-check: 52-week range $339–$764, centre $509 (+20% vs spot); spot sits at the 20th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV (FV ÷ price − 1) | $347 (-18% vs spot · triangulated FV) |
| Downside to lowest scenario (Structural — Defense-Budget Cuts / Aero-Production Halt) | $202 (-52% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Discount to fair value (1 − price ÷ FV) | -22% |
| P(price > spot) — Monte Carlo | 45% |
That ratio is (triangulated FV ÷ price − 1) ÷ (1 − 'Structural — Defense-Budget Cuts / Aero-Production Halt' target ÷ price). 'Structural — Defense-Budget Cuts / Aero-Production Halt' ($202, probability 20%) is the lowest-target scenario in the tree, taken gross of SBC dilution. With a leg missing the ratio is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate): $829.
Company Overview & Business Model
Axon Enterprise Inc. — INDUSTRIALS · AEROSPACE & DEFENSE. Axon Enterprise, Inc. develops, manufactures, and sells conducted energy weapons (DEC) under the TASER brand name in the United States and internationally. The company is headquartered in Scottsdale, Arizona.
Company description as supplied by Alpha Vantage; not checked against the company's filings.
How it makes money.
| Segment | Rev mix | Growth | Model op margin† | Key driver |
|---|---|---|---|---|
| Aerospace & Defense | 100% | +7% | 25% | defense budgets + commercial-aero OE/aftermarket cycle + program execution |
† Model margin = gross margin − the opex ratio calibrated so the Monte Carlo median EPS meets the EPS target; it is not a reported operating margin.
Reported operating margin (GAAP): -2.2% for the fiscal year ended 2025-12-31; 2.6% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).
Edge. Wide moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Model op margin† | Model EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Aerospace & Defense | $3.0B | 100% | 7% | 25% | $0.7B | 57.0x | 4% | ESTIMATE |
| † Model EBIT = revenue × the model margin, i.e. gross margin less the opex ratio the calibration solved for to meet the EPS target — not the company's reported operating income. |
For comparison, the company's reported GAAP operating margin was -2.2% for the fiscal year ended 2025-12-31; 2.6% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | defense budgets + commercial-aero OE/aftermarket cycle + program execution |
| net_debt_or_cash_b | -1.11 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | — |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | defense-budget cuts / aero-production halt |
| upside | rearmament + air-traffic recovery |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $0.2B — modestly levered |
| Net debt / EBITDA | 1.23x |
| Interest coverage (EBIT / interest) | 1.2x |
| Current ratio | 2.53x |
| Lease obligations | $0.1B |
| Cash & ST investments | $1.7B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $0.1B |
| Buybacks / dividends | $0.0B / $0.0B |
| Total shareholder yield | 0.0% |
| Payout as % of FCF | 0.0% |
| Reinvestment (capex / OCF) | 64.5% |
| SBC as % of FCF | 845.3% |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 2.5% |
| FCF conversion (FCF / net income) | 60.0% |
| FCF yield | 0.2% |
| Capex intensity (capex / revenue) | 4.5% |
| FCF − SBC (diagnostic) | $-0.6B |
| Capex split (maint / growth) | 40% / 60% — Capital-light software-plus-hardware model; capex skews to growth (cloud/data-center capacity, new-product manufacturing, R&D-adjacent tooling) rather than maintenance of a legacy base. |
Accounting quality: SBC 23% of revenue; cash conversion (OCF/NI) 169% — cash-backed.
Competitive Moat
Moat sources:
- Axon Evidence (Evidence.com) cloud lock-in with agency-wide data and workflow switching costs
- Taser device installed base + certification / training standardisation
- Multi-year enterprise agency contracts and bundled hardware-plus-software plans
- Regulatory/CJIS-compliant data infrastructure that competitors must rebuild
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.35 vs analyst floor +0.00 → delta +0.35 (n=47 mgmt / 21 Q&A; 36th pctile across the S&P book, z -0.4).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.35 | +0.00 | +0.35 |
| 2026Q1 | +0.59 | +0.03 | +0.56 |
| 2025Q4 | +0.48 | +0.01 | +0.47 |
| 2025Q3 | +0.56 | +0.11 | +0.46 |
News (last 365d, 1725 articles): avg ticker sentiment +0.14 (bullish 20% / bearish 5%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $704 (+66% vs spot · street) |
| House target | $430 (-39.0% vs street) |
| Sell-side coverage | 21 analysts (SB 8 / B 10 / H 2 / S 0 / SS 1; net score 0.57) |
| Consensus FY EPS | $7.65 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $3.7B; house below (-13.6%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-11-03 (~25d) — Quarterly earnings — est. EPS $0.48 (AV EARNINGS_CALENDAR)
- 2027-01-15 (~98d) — Large multi-year federal / state agency contract renewals (authored)
Forecast Track Record
- EPS surprise: beat 88% of the last 8 quarters; average surprise +28.2%.
Catalyst Timeline
5 catalysts in the next 90 days (of 13 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-10-14 (in 4d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 18d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-11-03 (in 24d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-12-09 (in 60d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 69d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-15 (in 97d) | Large multi-year federal / state agency contract renewals | authored | ● | 0.7 |
| 2027-01-27 (in 109d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 158d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 160d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 200d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 242d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 251d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-09-17 (in 342d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Government-budget dependence: federal/state/municipal spending squeeze on public-safety procurement | medium (~35%) | high - nearly all revenue is government-sourced; a sustained budget squeeze hits new bookings and the premium ~10-15% of FV | 12-24m |
| Police-use-of-force / civil-liberties scrutiny and data-privacy constraints on body-cam AI (e.g. facial-recognition limits) | medium (~30%) | medium - could cap the highest-margin AI roadmap ~4-6% of FV | 12-24m |
| Public-procurement / antitrust scrutiny of bundled sole-source contracting | low (~20%) | low - competitive friction but limited near-term FV impact ~2% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Defense-Budget Cuts / Aero-Production Halt | Sustained squeeze on federal, state and municipal public-safety budgets curtails new agency contracts and hardware refresh cycles | Government-budget austerity collapses new bookings while the 68x multiple leaves no earnings cushion |
| Cyclical Downturn — Air-Traffic / Program Recession | Cyclical municipal fiscal stress delays procurement and stretches refresh cycles without cancelling the installed base | Deferred hardware refresh slows the software attach flywheel and net revenue retention |
| Bull — Re-Rate | Risk-on tape sustains or expands the premium software multiple as the AI-attach narrative is rewarded | A multiple-driven re-rate on an already-68x stock is fragile to any growth or margin miss |
Scenario-macro rows withheld pending re-authoring: 2 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
1.63 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
1.63 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.57 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
168.8 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
0.86 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
1.24 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is what the model's own rules read on this name; it does not modify the published research rating, and it is not personal financial advice.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Total revenue growth, YoY < 0.04 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Operating margin < 0.233 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Full-year revenue guidance, $B < 3.2 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
- Annual capital expenditure, $B > 0.19 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
- Stock-based compensation as % of revenue > 0.25 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $423; 52-week range $339–$764; engine rating HOLD; house target $430 (+2%). (source: Alpha Vantage 2026-10-09, 10 October 2026)
- INFERENCE: Triangulated FV $347 (-18% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the DCF anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
59.8/100 (confidence band 46.4–73.2), 59th percentile of 893 covered names (as of 2026-10-09). Weighted composite under config ros-1.20.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 66 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 49 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 52 | 15% | upside_pct |
| growth | 57 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 88 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 85 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 24 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 60 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 60.8 → 61.1 → 61.1 → 61.2 → 61.4 → 60.6 → 60.3 → 60.1.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Defense-Budget Cuts / Aero-Production Halt | 20% | $202 | -52.2% | -10.4pp |
| Cyclical Downturn — Air-Traffic / Program Recession | 17% | $346 | -18.2% | -3.1pp |
| Base — Backlog + Aftermarket | 35% | $483 | +14.3% | +5.0pp |
| Growth — Rearmament / Air-Traffic Recovery | 20% | $649 | +53.6% | +10.7pp |
| Bull — Re-Rate | 8% | $829 | +96.0% | +7.7pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +9.9% |
| Expected return net of SBC dilution | +6.2% |
| Outcome dispersion (σ, from MC p10–p90) | 39.3% |
| Expected Sharpe (rf 4%) | 0.15 |
| Downside expectation (prob-weighted loss branches) | -13.5% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 9.9% |
| Risk-free rate | 4.49% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-10-08) |
| Beta (shrunk, 1y vs SPY) | 1.36 (as of 2026-10-09) |
| Equity risk premium | 4.5% |
| Required return | 10.6% |
| Expected alpha | -0.7% |
| Alpha per unit risk (EA/σ) | -0.02 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 43.4% (1σ) | 53.4% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 63.0% | 44.6% | the two expressions of our own view agree |
| Realised scenario frequency | 57 dated anchors | — | 57 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $464.64.
Factor Exposures
Cross-sectional percentiles over 893 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 65 | AI | 84 | |
| Value | 20 | Cloud | 98 | |
| Quality | 60 | Semis | 58 | |
| Momentum | 8 | Consumer | 95 | |
| Low-Vol | 3 | Rates | 83 | |
| USD | 15 | |||
| Energy | 2 |
Market interaction: correlation vs SPY +0.35, vs QQQ +0.33 (trailing ~1y daily returns).
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +6% vs spot
- Monte Carlo median implies -5% vs spot
- DCF fair value (exit-multiple terminal) implies -48% vs spot — but this is terminal-value sensitive (exit-multiple $221 vs Gordon $135, 39% apart), so it carries less weight
- Bear case (Structural — Defense-Budget Cuts / Aero-Production Halt) downside is -52% vs spot
- Net: the valuation anchor itself sits 18.0% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Model Appendix
DCF — line items
| Year | Revenue | Op income (house path) | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $3B | $1B | $0B | $0B | $1B | $1B |
| FY+2 | $3B | $1B | $0B | $0B | $1B | $1B |
| FY+3 | $4B | $1B | $0B | $0B | $1B | $1B |
| FY+4 | $4B | $1B | $0B | $0B | $1B | $1B |
| FY+5 | $4B | $1B | $0B | $0B | $1B | $1B |
| Terminal | — | — | — | — | $1B × 30.0x | $16B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.5% · Σ PV(FCF) $3B + PV(terminal) $16B = EV $19B; − net debt $1.1B → equity $18B ÷ diluted shares $0.08B = $221/share (exit-multiple terminal).
- Gordon terminal → $135/share — a single-point perpetual-growth cross-check at g = 2.5% (one growth rate, not a range; it is not in the blend).
- Incremental ROIC on the forecast capex ≈ 21% vs WACC 8.5% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| GE | 8.2x | 50.0x | 7% | 20% |
| RTX | 3.1x | 26.6x | 7% | 13% |
| LMT | 1.8x | 16.3x | 7% | 11% |
| HWM | 13.1x | 53.8x | 7% | 28% |
| Median | 5.7x | 38.3x | — | — |
Implied prices at the peer medians: same-sub-industry median fwd P/E → $294; EV/Rev → $198.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $221 | 31% (part weight ×0.64 — DCF sits 40%–70% from the Monte-Carlo/PWEV core) | $68.70 |
| Scenario PWEV | $449 | 34% | $155 |
| Monte Carlo median | $400 | 21% | $82.71 |
| Peer P/E | $294 | 14% | $40.51 |
| Triangulated | — | 100% | $347 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 8.5% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 30× | DCF exit value | house rule (0.85 × base multiple) |
| Terminal growth | 2.5% | Gordon cross-check (single point) | estimate |
| SBC dilution | 3.5%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (65.0); Terminal × ±15% (60.0); Model op margin ±3pp (57.0); WACC ±1pp (20.0); Capex intensity ±15% (17.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $3.0B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $3.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| FY+1 guided EPS | $7.6696 | company guidance | Company guidance | Medium | Forward P/E, scenarios |
| Consensus FY EPS | $7.6531 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.08B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $0.203B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 8.5% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 30× | house estimate | House rule: 0.85 × the base multiple (shared with the Monte Carlo) | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | Gordon cross-check (single point, not in the blend) |
| SBC dilution | 3.5%/yr | house estimate | From SBC/revenue | Medium | PWEV, MC, DCF (charged once) |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.20.0 |
| Analysis as-of | 2026-10-10 (prices 2026-10-09) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 8.5%, terminal multiple 30×, FY+5 revenue $4B. Triangulation leans 34% on PWEV, 31% on DCF, 21% on the Monte Carlo median, 14% on peer-implied value.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-10-09 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-10-09 |
| MCH engine — trailing 52 weeks of daily bars | derived | 2026-10-09 | 52-week range (intraday high and low over the trailing year of the stock's own daily bars) | trailing 52 weeks of own daily bars (intraday high/low, 2025-10-10 to 2026-10-08, 250 sessions) |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-09 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-09 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-09 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-10-09 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-10-09 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-10-09 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-10-09 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-10-09 | Segment revenue and multiple; model margin = gross margin − the calibrated opex ratio (not a reported margin) | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-10-09 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-10-09 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personal financial advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Analysis quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.